A stent is a tube inserted into the lumen of an anatomic vessel or duct to keep the passageway open for flow of blood or other fluids. Stents are made up of metals, ceramics, polymers, and other natural materials that are used in medical technology to improve the functionality of damaged organs and tissues. These stent materials are often used in medical implants such as artificial heart valves, intraocular lenses, and bone grafts. They serve as the ideal materials for fabricating implantable devices.
Factors such as rise in geriatric population, increase in prevalence of orthopedic & cardiovascular disorders, rise in demand for implantable devices, advancements in medical technology, and heavy funding by government agencies for the development of stent materials are the key factors that drive the growth of the global stent materials market. However, high cost of treatment associated with stent implants, increase in price of production of stent materials, complicated clinical & regulatory processes, and compatibility issues of materials are the factors that restrain the growth of the market. On the contrary, development of the healthcare sector in emerging economies and increase in free-trade agreements are expected to offer lucrative opportunities for market expansion.
The global stent materials market is segmented into material type, application, and region. According to material type, the market is categorized into metallic, polymeric, ceramic, and others. The metallic stent materials segment is expected to hold significant market share, due to increase demand for metals in the manufacturing of medical devices used in orthopedic, dental, and cardiovascular applications. By application, the market is classified into tissue engineering, surgery, wound healing, orthopedic, dental, cardiovascular, ophthalmology, and others.
Region wise, the global stent materials market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among these, Asia-Pacific is dominating the market, due to rise in prevalence of cardiovascular diseases and surge in geriatric population in the developing economies such as China & India.
The key players operating in the global stent materials market are Royal DSM, BASF SE, Corbion, Evonik Industries, Cam Bioceramics B.V., Berkeley Advanced Biomaterials, Celanese Corporation, CeramTec, Carpenter Technology Corporation, and GELITA AG. These players have acquired various strategies such as acquisitions, partnerships, collaboration, joint ventures, agreements, expansions, and new product launches to create a strong consumer base in the market. For instance, in July 2019, Royal DSM partnered with ProMed Pharma. This partnership helps Royal DSM to develop a novel sustained release drug delivery solution in the polymeric drug delivery area.
KEY BENEFITS FOR STAKEHOLDERS
- The report outlines the current market trends and future scenario of the stent materials market size to understand the prevailing opportunities and potential investment pockets.
- Porter’s five force analysis helps to analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.
- Major countries in the regions have been mapped according to their individual revenue contribution.
- The key drivers, restraints, and market opportunities and their detailed impact analysis are elucidated in the study.
- The stent materials market analysis covers in-depth information of major industry participants.
Stent Materials Market Report Highlights
| Aspects | Details |
 By Type |
|
 By APPLICATION |
|
 By Region |
|
 Key Market Players | Boston Scientific Corporation, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Corbion, GELITA AG, Evonik Industries, Cam Bioceramics B.V., Celanese Corporatione, BASF SE, CeramTec |
Loading Table Of Content...
